eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | non-alcoholic fatty liver disease |
| Comorbidity | C0019196|hepatitis c |
| Sentences | 6 |
| PubMedID- 21645344 | In this article we discuss several liver conditions which are directly affected by overweight and obese status, including non-alcoholic fatty liver disease, chronic infection with hepatitis c virus and post-liver transplant status. |
| PubMedID- 22087124 | Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis c treated with alpha-interferon and ribavirin: rosuvastatin reduces nafld in hcv patients. |
| PubMedID- 26138651 | Background: rising rates of obesity, diabetes mellitus (dm), and nonalcoholic fatty liver disease among patients with chronic hepatitis c virus infection (hcv) may contribute to more rapid disease progression. |
| PubMedID- 23630437 | Status of essential trace minerals and oxidative stress in viral hepatitis c patients with nonalcoholic fatty liver disease. |
| PubMedID- 25553983 | The association of nafld with chronic hepatitis c (chc) has been extensively studied but little is known about its coexistence with chronic hepatitis b (chb). |
| PubMedID- 26078820 | Related to this, nafld in hepatitis c virus patients is associated with oxidative damage, likely due to imbalances in trace metals [74]. |
Page: 1